The holder of an intellectual property right protecting the appearance and texture of the oral pharmaceutical forms of a reference medicinal product within the meaning of Article L. 5121-1 may not prohibit the oral pharmaceutical forms of a generic medicinal product that may be substituted for this medicinal product pursuant to Article L. 5125-23 from having an identical or similar appearance and texture.